Lincluden Management’s Thermo Fisher Scientific TMO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$9.45M Sell
13,994
-2,793
-17% -$1.66M 0.92% 24
2026
Q2
$8.42M Buy
16,787
+2,366
+16% +$1.14M 0.83% 24
2026
Q1
$7.09M Buy
14,421
+3,178
+28% +$1.72M 0.75% 29
2025
Q4
$6.52M Sell
11,243
-3,506
-24% -$1.98M 0.55% 35
2025
Q3
$7.15M Buy
14,749
+1,121
+8% +$522K 0.8% 27
2025
Q2
$5.53M Buy
+13,628
New +$5.7M 0.61% 34

Other funds holding TMO

Lincluden Management's TMO Position: Q3 2026 in Review

Lincluden Management reduced its Thermo Fisher Scientific (TMO) stake by 17% in Q3 2026, selling an estimated $1.66M and leaving 13,994 shares worth $9.45M. The position accounts for 0.92% of the portfolio, ranked #24.

Lincluden Management first reported a position in TMO in Q2 2025 and has held it in 6 quarters since. 1,807 funds tracked by Wall St. Rank hold TMO as of Q3 2026.

  • Lincluden Management held 13,994 shares of Thermo Fisher Scientific worth $9.45M as of Q3 2026.
  • Lincluden Management sold 2,793 Thermo Fisher Scientific shares in Q3 2026, an estimated $1.66M.
  • Thermo Fisher Scientific made up 0.92% of Lincluden Management's portfolio in Q3 2026, its #24 holding.
  • Lincluden Management first reported a position in Thermo Fisher Scientific in Q2 2025 and has held it in 6 quarters since.
  • 1,807 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q3 2026.

Based on Lincluden Management's 13F filing for Q3 2026, filed 28 Oct 2026.